Spark Therapeutics announces collaboration with leading gene therapy center at UMass
Spark Therapeutics announced a multi-year research agreement with the Horae Gene Therapy Center which collaborate broadly with Spark Therapeutics to identify AAV vectors from a proprietary library of AAV capsids and evaluate their efficacy, with the goal of enhancing the efficiency of gene delivery. October 20, 2016